Evaluation of Congestion Markers at Hospital Discharge in Adults with Acute Heart Failure and Reduced Ejection Fraction

What this Trial Is About

Researchers are studying patients with acute heart failure who have reduced ejection fraction and are hospitalized for worsening heart failure. The study aims to identify markers of congestionsuch as clinical signs, biological data, and ultrasound findingsat the time of hospital discharge that could be linked to the risk of death or rehospitalization within three months after leaving the hospital. Participants will undergo clinical exams focused on congestion, various Doppler ultrasounds of the heart and other organs, blood sample collection for biological tests and storage, and complete quality of life questionnaires. These evaluations take place before hospital discharge. Follow-up includes telephone interviews and quality of life assessments at 3, 12, and 24 months after discharge. During the study, participants will have clinical exams, ultrasounds, blood tests, and questionnaires before discharge, followed by phone interviews at set intervals to monitor their condition. Researchers will measure outcomes such as rates of death, rehospitalization, intravenous diuretic treatments, heart function class, kidney function, and quality of life over 24 months. This monitoring helps assess markers linked to heart failure outcomes over time.

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation